Conexeu Sciences INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Michael G. Wright has reported beneficial ownership of 12.1% of Conexeu Sciences Inc. common stock as of June 30, 2026.
NASDAQ
Paisley Capital Holdings Corp. has reported beneficial ownership of 1,800,000 shares, representing 6.7% of the common stock of Conexeu Sciences Inc.